Try our beta test site
116 studies found for:    hemophilia | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.
Conditions: Haemophilia;   Developing Countries
Interventions: Other: Education;   Diagnostic Test: Improve biological diagnosis and follow-up of haemophilia;   Drug: Implement haemostatic non substitutive care of haemophilia;   Other: Implement non haemostatic care of haemophilia
2 Recruiting TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia
Condition: Haemophilia A
Intervention: Other: Thrombin generation measurement.
3 Recruiting Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia
Condition: Haemophilia
Intervention: Other: Patients with haemophilia
4 Recruiting The Hemophilia Ultrasound Project
Conditions: Hemophilia A;   Hemophilia B
Interventions: Other: Ankle and Knee Ultrasound Joint Assessment;   Other: Ankle and Knee Magnetic Resonance Imaging
5 Not yet recruiting Hemophilia Inhibitor Prevention (INHIBIT) Trial
Condition: Severe Hemophilia A
Intervention: Drug: Long-acting recombinant factor VIII Fc fusion protein
6 Recruiting Assessment of Proprioceptive and Functional Characteristics in Patients With Hemophilia
Condition: Hemophilia
Intervention:
7 Recruiting Adherence to Treatment in Hemophilia
Condition: Haemophilia
Intervention:
8 Not yet recruiting Does the Thrombin Generation Test Performed During the Pharmacokinetic Profile of the Substitutive Factor VIII Bring Benefits to the Personalized Treatment of Pediatric Patients and Adult Hemophilia A Patients Under Prophylaxis ?
Condition: Hemophilia
Interventions: Device: Chronometric method;   Device: Chromogenic method;   Device: Thrombin generation test (TGT)
9 Recruiting Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
Condition: Hemophilia A
Intervention: Drug: Available Recombinant, and Human Factor VIII products incl. Kogenate FS (Recombinant Factor VIII, BAY14-2222)
10 Not yet recruiting Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography
Condition: Hemophilia A With Inhibitors
Intervention: Other: Thromboelastography-Guided Treatment Regimen
11 Recruiting Factor Product Utilization and Health Outcomes in Patients With Hemophilia
Conditions: Hemophilia A, Congenital;   Hemophilia B, Congenital
Intervention:
12 Recruiting Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: Gene Transfer
13 Recruiting A Study of Once-Weekly Emicizumab in Children and Adolescents With Hemophilia A and Factor VIII (FVIII) Inhibitors (HAVEN 2)
Condition: Hemophilia A
Intervention: Drug: Emicizumab
14 Recruiting Weight-based Dosing in Hemophilia A
Condition: Hemophilia
Intervention: Drug: rFVIII
15 Recruiting National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A
Condition: Hemophilia A
Intervention: Behavioral: Educational Package
16 Not yet recruiting A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B
Conditions: Haemophilia A;   Haemophilia B
Interventions: Drug: ELOCTA;   Drug: ALPROLIX
17 Recruiting Hemophilia Inhibitor Previously Untreated Patient Study
Condition: Hemophilia A
Intervention: Drug: FVIII concentrate
18 Recruiting ATHN 2: Factor Switching Study
Condition: Hemophilia
Interventions: Biological: Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013;   Biological: Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013
19 Recruiting German Pediatric Hemophilia Research Database
Conditions: Hemophilia A;   Hemophilia B;   Children;   Drug Specific Antibodies
Intervention: Other: documentation only
20 Not yet recruiting PF-06741086 Multiple Dose Study in Severe Hemophilia
Condition: Hemophilia A or B
Intervention: Biological: PF-06741086

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.